ImmunoGen

ImmunoGen

Employees:
310
Market Cap:
$536.87 million
Revenue:
$40.76 million
5 Year Trend:
25.4%
Net Income:
$-104.52 million
NASDAQ:
IMGN

ImmunoGen, Inc. (NASDAQ: IMGN) is a biotechnology company focused on the development of antibody-drug conjugate (ADC) therapeutics for the treatment of cancer. ImmunoGen was founded in 1981 and is headquartered in Waltham, Massachusetts. Wikipedia

ImmunoGen

Employees:
310
Market Cap:
$536.87 million
Revenue:
$40.76 million
5 Year Trend:
25.4%
Net Income:
$-104.52 million
NASDAQ:
IMGN

ImmunoGen, Inc. (NASDAQ: IMGN) is a biotechnology company focused on the development of antibody-drug conjugate (ADC) therapeutics for the treatment of cancer. ImmunoGen was founded in 1981 and is headquartered in Waltham, Massachusetts. Wikipedia